If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Qynapse"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
Line 1: | Line 1: | ||
+ | [[Category:LinkedIn Accounts]] | ||
+ | [[Category:Twitter Accounts]] | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
[[Category:Companies]] | [[Category:Companies]] | ||
Line 16: | Line 18: | ||
[https://www.crunchbase.com/organization/qynapse Crunchbase] | [https://www.crunchbase.com/organization/qynapse Crunchbase] | ||
[https://www.linkedin.com/company/qynapse/ LinkedIn] | [https://www.linkedin.com/company/qynapse/ LinkedIn] | ||
− | [https://twitter.com/qynapse | + | [https://twitter.com/qynapse Twitter] |
Revision as of 15:38, 23 March 2022
Qynapse unlocks the potential of quantitative #imaging and #AI to optimize diagnosis, prognosis and monitoring of patients suffering from neurological disorders.
Founded in France around 2015, Qynapse produces end-user software.
Qynapse makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Efferent
Neurosensing Technique(s): MRI